CD79A and COVID-19: To study the antibody response to SARS-CoV-2, we tested for IgG, IgA, and IgM antibodies to the S protein and RBD in pre-COVID-19 controls (n = 520), resolved COVID-19 subjects (n = 153), and RT-PCR-negative subjects (n = 55).